NPA Urges California to Weigh Enforcement of Legislation Restricting Access to Dietary Supplements


On Sept. 8, Following the passage of California’s AB 1341, which restricts access to dietary supplements and, in certain situations, requires a prescription to access these health products, the Natural Products Association (NPA) sent a letter to the California Department of Public Health Director Tomas J. Aragón urging the director to recognize the importance of dietary supplementation and the scientific evidence from the Food and Drug Administration (FDA) showing there is no correlation between dietary supplement use and eating disorders.

“In 2019 and 2022, we filed Freedom of Information Act (FOIA) inquiries to the FDA to explore any adverse events for any cases involving eating disorders and dietary supplements. According to the chief regulator of dietary supplements, the FDA, there is no data point connecting the two,” said Daniel Fabricant, PhD, president and CEO of NPA.

“Americans relied on dietary supplements to help support their health during the pandemic. Now, Californians may have to have a prescription to gain access to those nutrient rich [products]. This is misguided legislation that is based on abject falsehoods claiming that there is some connection between supplements and eating disorders when the official federal official government data shows that no connection exists.  We will use every resource and avenue—including potential litigation—in order to fight back against this proposal in California and across the country.”

NPA has led the fight as the only trade organization opposing AB 1341 and similar proposals in New York, New Jersey, Massachusetts, Missouri and Rhode Island. NPA has activated its national grassroots network and is urging the industry to urge Governor Newsom to veto this legislation.

For more information, visit www.npanational.org.

On Sept. 8, Following the passage of California’s AB 1341, which restricts access to dietary supplements and, in certain situations, requires a prescription to access these health products, the Natural Products Association (NPA) sent a letter to the California Department of Public Health Director Tomas J. Aragón urging the director to recognize the importance of dietary supplementation and the scientific evidence from the Food and Drug Administration (FDA) showing there is no correlation between dietary supplement use and eating disorders.

“In 2019 and 2022, we filed Freedom of Information Act (FOIA) inquiries to the FDA to explore any adverse events for any cases involving eating disorders and dietary supplements. According to the chief regulator of dietary supplements, the FDA, there is no data point connecting the two,” said Daniel Fabricant, PhD, president and CEO of NPA.

“Americans relied on dietary supplements to help support their health during the pandemic. Now, Californians may have to have a prescription to gain access to those nutrient rich [products]. This is misguided legislation that is based on abject falsehoods claiming that there is some connection between supplements and eating disorders when the official federal official government data shows that no connection exists.  We will use every resource and avenue—including potential litigation—in order to fight back against this proposal in California and across the country.”

NPA has led the fight as the only trade organization opposing AB 1341 and similar proposals in New York, New Jersey, Massachusetts, Missouri and Rhode Island. NPA has activated its national grassroots network and is urging the industry to urge Governor Newsom to veto this legislation.

SR Carnosyn
CapsCanada





Source link

Comments are closed.